The award will help fund development of the firm's "ksim" algorithm to determine infection relatedness in suspected hospital-acquired infection outbreaks.
A Personalized Medicine Coalition-funded study has found that NGS-based testing is moderately cost effective but that access to targeted treatments remains a hurdle.
Bloomberg reports that some of genetic testing firm Vitagene's records were exposed online, including ones containing genetic information.
The Wall Street Journal writes that fast-tracked drug approvals are becoming routine.
The California Institute for Regenerative Medicine is running out of funding, according to ScienceInsider.
In Genome Biology this week: methylation and gene expression profiles in schizophrenia, genomic variation and selection in the mustard plant, and more.
Five hundred pharmacies will provide information about pharmacogenetic testing to members who have failed one or more antidepressant treatments.
An analysis of biology conferences appearing in the Proceedings of the National Academy of Sciences finds that few have codes of conduct.
NPR reports on the slower-than-predicted uptake of newborn genome sequencing.
In PNAS this week: characterization of an alternatively spliced autism-linked gene, horizontal gene transfer in soil bacteria, and more.
23andMe is offering early customers re-testing on newer chips for a fee, Wired reports.
He Jiankui is no longer affiliated with Direct Genomics Biotechnology, the single molecule sequencing company he founded, Nikkei Asian Review reports.
Newsweek writes about the hopes for precision medicine in cancer, but also challenges getting it to patients.
In Genome Research this week: genomic architecture of glioblastoma, predictive computational approach to estimate SNP fitness, and more.